ApopLogic Pharmaceuticals, Inc.

ApopLogic Pharmaceuticals is a clinical stage biopharmaceutical company developing targeted small molecule drugs and biologics to treat cancer.

  • Stage Not Set
  • Industry Biotechnology
  • Location Aurora, CO, USA
  • Currency USD
  • Employees 0
  • Website apoplogic.com

Company Summary

Team

  • Richard Duke, PhD
    Acting CEO

  • Paul Bunn, MD
    Acting CMO

  • Donald Bellgrau, PhD
    Acting VP-Research

  • Jaime Modiano, VMD, PhD
    Acting VP-Canine Onc

  • Rick Duke

Advisors

  • Cooley (Corporate); Morrison and Foerster (IP); Sheridan Ross (IP)
    Lawyer
    Unconfirmed
    Mullins + Assoc
    Accountant
    Unconfirmed

Previous Investors

  • Life Science Angels (Palo Alto) ($420K)|Private Investors (Denver) ($375K)|ULEHI (Boulder) ($100K)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free